White Karen Ann's Form 4 filing
GeneDx Holdings Corp. (WGS) · filed Jul 5, 2023
- Accession no.
- 0001209191-23-041212
- Filed
- Jul 5, 2023
- Trade date
- Jul 1-3, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $269.55. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| White Karen AnnCIK 0001874118 | Officer (Chief People Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2023 | Class A Common Stock | MOption exerciseAcquired | +99 | –F1 | – | 4,730 | Direct | |
| Jul 3, 2023 | Class A Common Stock | SSaleDisposed | −45 | $5.99 | −$269.55 | 4,685 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2023 | Class A Common Stock | MOption exerciseDisposed | −99 | $0.00 | $0 | 1,092 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
Referenced by the price of 1 transaction in Table I.